
A recent study of pregnancies from the Quebec Pregnancy Cohort found use of antidepressants during pregnancy was linked to an increased rate of gestational diabetes mellitus in an analysis that included more than 200,000 women from 1998 to 2015.
Patrick Campbell is the editorial director of HCPLive. Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter and/or multimedia specialist with the Pocono Record, Star News Group, and NJ Advance Media. He is the executive producer for multiple HCPLive podcasts, including Diabetes Dialogue, Don't Miss a Beat, Kidney Compass, Medical Ethics Unpacked, The Medical Sisterhood, and Skin of Color Savvy.
Follow him on Twitter @RealPatCampbell or reach him via email at [email protected].

A recent study of pregnancies from the Quebec Pregnancy Cohort found use of antidepressants during pregnancy was linked to an increased rate of gestational diabetes mellitus in an analysis that included more than 200,000 women from 1998 to 2015.

Gail Rodich, MD, discusses what the approval of rituximab, which has approvals for 9 other conditions including rheumatoid arthritis, means for pediatric patients with GPA and MPA.

Vanita Aroda, MD, of Brigham and Women's Hospital, discusses the impact of PIONEER trials and the implications the approval for oral semaglutide has on diabetes care.

A recent study into insulin use in adults 75 and older found insulin use was increased in those with worse health, indicating a lack of adherence to current guideline recommendations.

A study from cardiologists at UPMC Children's Hospital of Pittsburgh examining changes to criteria in 2016, which aimed to improve mortality rates among pediatric candidates for heart transplantation, found rates have worsened for certain conditions.

On this episode of the DocTalk Podcast, Lakiea Wright, MD, of Brigham and Women's Hospital and Thermo Fisher Scientific, discusses the impact of changing seasons and climate on allergies and asthma.

A Johns Hopkins University study found that donating a kidney was linked to a 19% increase in developing hypertension, regardless of a patient's race.

A recent analysis of 24 studies found that many medical students or recent graduates feel their education on nutrition was lacking during medical training.

A new American Heart Association and National Institutes of Health-sponsored study found that use of a polypill reduced cardiovascular risk in a low-income population in Mobile, Alabama.

A recent study examining use of popular glucose-lowering medications found that metformin use was associated with fewer cardiovascular events in diabetic patients with reduced kidney function.

A new meta-analysis presented at EASD 2019 found that women who gave birth following use of assisted reproductive techniques had a 53% increased risk of gestational diabetes compared to women who conceived naturally.

The American Academy of Neurology has published recommendations of 6 quality measurements to help improve care and treatment of patients with mild cognitive impairment.

Shaquille O'Neal, EdD, and Elizabeth Ofili, MD, discuss how organizations and physicians are taking novel approaches to engage patients and non-patients about heart failure.

Shaquille O'Neal and Elizabeth Ofili, MD, sit down to discuss Shaq Gets Real, which is a new campaign from Arbor Pharmaceuticals to increase awareness of the disparities in heart failure rates in the African American community.

Elizabeth Ofili, MD, discusses the importance of annual meetings, such as HFSA 2019, for outreach and engaging patient populations about heart failure.

Shaquille O'Neal, Ed.D, and Elizabeth Ofili, MD, discuss using unconventional mediums to engage non-patients and spread awarness of heart failure — specifically in African Americans.

A proof of concept trial examining spironolactone for heart failure prevention presented at HFSA 2019 found spironolactone use did reduce PIIINP or that its impact on PIIINP was mitigated by galectin-3.

Results of the AMBER study, presented at HFSA 2019, found that patiromer can help improve spironolactone use while also reducing the prevalence of hyperkalemia.

A study presented at HFSA 2019 Scientific Sessions found that virtual visits were a feasible option that could reduce no-show rates among heart failure patients following hospitalization.

Fast Track designation comes about a month after dapagliflozin received another Fast Track designation for delaying the progression of renal failure and prevent CV and renal death in patients with chronic kidney disease

Albert Rizzo, MD, the chief medical officer of the American Language Association, answers questions about and discusses the dangers of vaping and e-cigarette use in the latest edition of the DocTalk Podcast.

A study from Brigham and Women's Hospital found asking clinicians if they would be surprised if older patients would die in the next month could save patients money on healthcare and improve quality of end-of-life care.

A recent analysis that included data on 284 patients found that more than 80% of patients with resistant hypertension also had obstructive sleep apnea.

A group of 370 leading healthcare organizations have sent a letter to congress in support of a bipartisan bill that would protect Medicare Advantage Beneficiaries from delays caused by prior authorizations.

A recent study found the lifetime risk of peripheral artery disease in black patients was around 30% while Hispanic and white patients had prevalence rates around 20%.

FDA announced the approval of the glucagon (Gvoke) injection for the treatment of severe hypoglycemic events in diabetic patients ages 2 and up on September 10.

A recent study found that 10% of the drugs and devices approved by the FDA during the study period were based on non-randomized clinical trials.

A recent study from investigators at the Rutgers Robert Wood Medical School found that rates of hypertension among pregnant women have spiked between 1970 and 2010.

Analysis of the FAST trial found that methotrexate performed better head-to-head than mycophenolate mofetil as a corticosteroid-sparing therapy.

Deepak Bhatt, MD, executive director of Interventional Cardiovascular Programs at Brigham and Women's Hospital, offers perspective on the THEMIS and THEMIS-PCI trials.